Biological
Typhoid conjugate vaccine
Typhoid conjugate vaccine is a biological therapy with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 42 (66.7%)
Trials by Status
recruiting125%
not_yet_recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
completedphase_4
Vellore Typhoid Vaccine Impact Trial
NCT05500482
not_yet_recruitingphase_4
Opportunistic Pneumococcal Immunisation Trial in MALnutrition
NCT06817421
recruitingphase_2
Infant Malaria Vaccine Schedule Optimization
NCT06879327
completed
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India
NCT03554213
Clinical Trials (4)
Showing 4 of 4 trials
NCT05500482Phase 4
Vellore Typhoid Vaccine Impact Trial
NCT06817421Phase 4
Opportunistic Pneumococcal Immunisation Trial in MALnutrition
NCT06879327Phase 2
Infant Malaria Vaccine Schedule Optimization
NCT03554213
Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4